Indomethacin with or without prophylactic pancreatic stent placement to prevent pancreatitis after ERCP: a randomised non-inferiority trial
B. Joseph Elmunzer(University of Michigan–Ann Arbor), Richard S. Kwon(University of Michigan), Rajesh N. Keswani(Northwestern University), Collins Ordiah(Medical University of South Carolina), Gregory A. Coté(University Medical Center), Ji Young Bang(Orlando Health), Alan Barkun(McGill University Health Centre), Nauzer Forbes(University of Calgary), José Serrano(National Institutes of Health), Cathie Spino(University of Michigan), Timothy B. Gardner(Dartmouth College), Rebecca L. Spitzer(Brigham and Women's Hospital), Andrew Y. Wang(University of Virginia), Shyam Varadarajulu(Orlando Health), Field F. Willingham(Emory University), Raj J. Shah(University of Colorado Anschutz Medical Campus), Georgios I. Papachristou(University of Pittsburgh), Yen‐I Chen(Johns Hopkins University), Patrick Yachimski(Vanderbilt University Medical Center), Steven Keilin(Emory University), Daniel Mullady(University of Pittsburgh), Steven A. Edmundowicz(Washington University Medical Center), Zachary L. Smith(Washington University in St. Louis), Sachin Wani(University of Colorado Anschutz Medical Campus), Vladimir Kushnir(Washington University in St. Louis), Amitabh Chak(University Hospitals Cleveland Medical Center), John R. Saltzman(Brigham and Women's Hospital), Lydia D. Foster(Medical University of South Carolina), Vikesh K. Singh(Johns Hopkins University), Andrew S. Ross(Commonwealth Scientific and Industrial Research Organisation), Joanna K. Law(Johns Hopkins Hospital), Bret T. Petersen(Medical College of Wisconsin), James Buxbaum(University of Southern California), James M. Scheiman(University of Michigan), Adam Slivka(University of Pittsburgh Medical Center), Amit Rastogi(University of Kansas), Valerie Durkalski‐Mauldin(Medical University of South Carolina), Mouen A. Khashab(Johns Hopkins University)
Cited by 106
Related Papers
Radiofrequency Ablation in Barrett's Esophagus with Dysplasia
|New England Journal of Medicine|2009|1.4k
Celecoxib for the Prevention of Sporadic Colorectal Adenomas
|New England Journal of Medicine|2006|1k